Keeping Current

521 Episodes

1. Treating MS Early: Who, How, and When?

   Published: 6/14/2021
2. Bispecific Antibodies: The Case for Non-BCMA Targets

   Published: 6/11/2021
3. Tackling Adherence in Dyslipidemia: Concrete Actions for Better Outcomes

   Published: 6/4/2021
4. SARS-CoV-2 Vaccine Candidates: Expertise and Updates

   Published: 6/4/2021
5. Practical Strategies to Overcome Poor Vaccine Uptake During the COVID-19 Pandemic

   Published: 6/4/2021
6. COVID-19: The Path to Immunity

   Published: 6/3/2021
7. Optimal Implementation of the COVID-19 Vaccine: Best Practice and Strategies for Success

   Published: 6/2/2021
8. Beyond Clinical Trials: Treating nAMD in Clinical Practice

   Published: 5/27/2021
9. Molecularly Guided Therapy in Oncology Practice: The Evolving State of the Art

   Published: 5/25/2021
10. ENDO 2021 – New Directions With Weight Loss Concepts of the Future

    Published: 5/25/2021
11. Taking Control of Chronic Spontaneous Urticaria: A Tale of Two Perspectives

    Published: 5/19/2021
12. Advances in Oncogene-Driven Metastatic NSCLC: Focusing on EFGR Exon 20 Insertions and ALK-Positive NSCLC

    Published: 5/11/2021
13. HFpEF Is Arguably the Greatest Unmet Need in Cardiology: The Potential Role of SGLT2 Inhibitors

    Published: 5/6/2021
14. Patient Engagement in MS: What Does This Mean and What Does It Look Like?

    Published: 5/5/2021
15. Neuro-Ophthalmology: What You Need to Know About LHON

    Published: 4/30/2021
16. The Science of MS and Role of S1P Receptor Modulators

    Published: 4/30/2021
17. Emerging Therapies for Chronic Spontaneous Urticaria: Understanding How They Work

    Published: 4/21/2021
18. Molecular Testing – Transplant and Treatment Strategies in AML

    Published: 4/21/2021
19. New Approaches to Ocular Surface Pain

    Published: 4/19/2021
20. Defining NASH As a Metabolic Disease: Can We Afford to Ignore It?

    Published: 4/19/2021